Pharmaceutical ingredient manufacturing firm Valiant Laboratories has decided to launch its initial share sale for public subscription on September 27. The Initial Public Offering (IPO), which is an entirely fresh issuance of 1.08 crore equity shares with no offer for sale component, will be concluded on October 3, according to the red herring prospectus filed with Sebi on Friday. Further, bidding for anchor investors will open on September 26. Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary -- Valiant Advanced Sciences Private Ltd. -- and to meet the working capital requirements of the subsidiary company. Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, which is used in the treatment of headache, muscle ache, arthritis, backache, toothache, cold and fever. The paracetamol API industry grew from Rs 2,200 cr
The IPO of Zaggle Prepaid Ocean Services saw over 12 times more demand than shares on offer
The IPO of Zaggle Prepais Ocean Services was subscribed 19 per cent on Thursday, the first day of its issue
As on June 2023, IREDA's portfolio of outstanding term loans stood at Rs 47,206.66 crore. The company's term loans outstanding are spread across 23 states
Taku said that the company plans on tapping into new investments if it is working on a new product or an inorganic play that requires capital
The initial public offering (IPO) of Jupiter Lifeline Hospitals was subscribed 3.3 times on Thursday, the second day of the issue
OYO refiled its Draft Red Herring Prospectus (DRHP) with the stock market regulator SEBI under the recently introduced pre-filing route in March
The initial public offering (IPO) of Jupiter Lifeline Hospitals was subscribed 87 per cent on Wednesday, the first day of the issue
Gurugram-based Samhi Hotels and Jaipur-based Motisons Jewellers have received final observation from Sebi
As of July 31, Arkade had developed 1.8 million square feet of residential property. Its revenue in FY23 stood at Rs 224 crore
Analysts said the selling pressure on the stock could ease over the next few days. Investors are also looking for cues from RIL's annual general meeting (AGM) on Monday
Backed by famed investor Ashish Kacholia, Aeroflex has priced its issue between Rs 102 and Rs 108 a share
Famed investor Ashish Kacholia-backed Aeroflex has priced its issue between Rs 102 to Rs 108. At the top-end, Aeroflex is valued nearly Rs 1,400 crore
HR services firm is separately seeking to raise Rs 200 cre through private equity investments
The Morgan Stanley Capital International (MSCI) India Index witnessed a sharp drop of over 9 per cent on Friday
The issue will open for subscription from July 26 to July 28 while anchor investors will be able to bid on July 25
Netweb has set Rs 475-500 as the price band for its maiden share sale. At the upper end of the price band, the company is valued at Rs 2,803 crore, nearly 60 times on FY23 earnings
The company is issuing fresh shares worth Rs 500 crore in the IPO, which will be used for augmenting the bank's tier-1 capital base
The IPO now includes an issue of fresh equity shares amounting to Rs. 486.74 crore and an offer for sale (OFS) of Rs. 142.3 crore
The offering includes a provision to reserve 1% of the total issue size for its employees, equating to Rs. 5 crore shares